• 4808 Citations
  • 34 h-Index
1991 …2019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where YoungTae Kim is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 22 Similar Profiles
Ovarian Neoplasms Medicine & Life Sciences
Uterine Cervical Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Hysterectomy Medicine & Life Sciences
Carcinoma Medicine & Life Sciences
Laparoscopy Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Endometrial Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1991 2019

Adenosine triphosphate-based chemotherapy response assay predicts long-Term survival of primary epithelial ovarian cancer

Li, L. Y., Kim, S. W., Nam, E. J., Lee, J., Kim, S. & Kim, Y. T., 2019 Feb 1, In : International Journal of Gynecological Cancer. 29, 2, p. 334-340 7 p.

Research output: Contribution to journalArticle

Carboplatin
Adenosine Triphosphate
Drug Therapy
Survival
Recurrence
1 Citation (Scopus)

Genetic profiles associated with chemoresistance in patient-derived xenograft models of ovarian cancer

Li, L. Y., Kim, H. J., Park, S. A., Lee, S. H., Kim, L. K., Lee, J. Y., Kim, S., Kim, Y. T., Kim, S. W. & Nam, E. J., 2019 Jul 1, In : Cancer Research and Treatment. 51, 3, p. 1117-1127 11 p.

Research output: Contribution to journalArticle

Open Access
Heterografts
Ovarian Neoplasms
Atlases
Neoplasms
Exome
2 Citations (Scopus)
Paclitaxel
Ovarian Neoplasms
Drug Therapy
Survival
Tumor Burden

Pretreatment lymphocytopenia is an adverse prognostic biomarker in advanced-stage ovarian cancer

Lee, Y. J., Chung, Y. S., Lee, J. Y., Nam, E. J., Kim, S. W., Kim, S. & Kim, Y. T., 2019 Feb 1, In : Cancer medicine. 8, 2, p. 564-571 8 p.

Research output: Contribution to journalArticle

Open Access
Lymphopenia
Ovarian Neoplasms
Biomarkers
Lymphocyte Count
Multivariate Analysis
1 Citation (Scopus)

Prognostic significance of CA-125 re-elevation after interval debulking surgery in patients with advanced-stage ovarian cancer undergoing neoadjuvant chemotherapy

Lee, Y. J., Chung, Y. S., Lee, J. Y., Nam, E. J., Kim, S. W., Kim, S. & Kim, Y., 2019 Apr 1, In : European Journal of Surgical Oncology. 45, 4, p. 644-649 6 p.

Research output: Contribution to journalArticle

Ovarian Neoplasms
Antigens
Drug Therapy
Neoplasms
Confidence Intervals